As compared with the B cell-control RA-CD4+ T cell co-culture group (B + TCON), the percentage of CD138+ plasma cells decreased in the B cell + IGU treated RA-CD4+ T cell co-culture group (B + TIGU) (Figure 1B). This evidence concerns the gene SDC1 and rheumatoid arthritis.